Concepedia

Ryan Dittamore

RD

37

Publications

3.9K

Citations

29

H-Index

2013

Active since

Affiliations

Epic Sciences (United States)(Current)

Cornell University

Memorial Sloan Kettering Cancer Center

University of Michigan

Johns Hopkins University

Ryan Dittamore is an author at Epic Sciences (United States) specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

2013–2021

37

Publications

37

Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer

Howard I. Scher, David Lu, Nicole A. Schreiber et al. · JAMA Oncology · 2016 · 627 citations · Full text

Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study

Andrew J. Armstrong, Susan Halabi, Jun Luo et al. · Journal of Clinical Oncology · 2019 · 354 citations · Full text

Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations

Fatima Karzai, David James VanderWeele, Ravi A. Madan et al. · Journal for ImmunoTherapy of Cancer · 2018 · 295 citations · Full text

Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer

Karen A. Autio, Robert Dreicer, Justine Anderson et al. · JAMA Oncology · 2018 · 241 citations · Full text

Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer

Howard I. Scher, Ryon P. Graf, Nicole A. Schreiber et al. · JAMA Oncology · 2018 · 237 citations · Full text

Rows per page

1–5 of 37